WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles:
Related suggestion:
Nation's NEV output hits milestoneDraft rules to improve data security releasedWang urges UK to take ties back on trackYouth employment rate may improve in AugustSouth China theater festival to showcase outstanding classicsChina Focus: Vibrant festival highlights cultural charm of various Chinese ethnic groupsXi Meets Dutch PM in BeijingChinese FM mourns passing of renowned Japanese conductor Seiji OzawaNew UK sanctions targeting Chinese companies over Ukraine crisis are unilateralism:embassyFrench President Macron meets visiting Chinese Foreign Minister Wang Yi
0.2998s , 6488.578125 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,International Intricacies news portal